Price
No data yet.
Social Signal Score
Analyst Ratings
21 analystsRevenue
$221.17M+716.43%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Patrick S. Miles
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 913
- Beta
- 0.78
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- -0.59
Financials
Revenue
$221.17M+716.4%Net Income
$-5.47MEBITDA
$23.62MFree Cash Flow
$5.57MEPS (diluted)
$-0.03Shares Outstanding (diluted)
157.38M+1759.1%Operating Expenses
$150.51MCash & Debt
$79.94MReturn of Capital
$0.00Revenue by Segment (annual)
$764.15MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $764.15M | $-143.36M | $-0.96 |
| 2024 | $611.56M | $-162.12M | $-1.13 |
| 2023 | $482.26M | $-186.64M | $-1.54 |
| 2022 | $350.87M | $-151.29M | $-1.47 |
| 2021 | $243.21M | $-143.03M | $-1.50 |
| 2020 | $144.86M | $-78.99M | $-1.18 |
| 2019 | $113.43M | $-57.00M | $-1.09 |
| 2018 | $91.69M | $-28.98M | $-0.82 |
| 2017 | $101.74M | $-2.29M | $-0.18 |
| 2016 | $120.25M | $-30.32M | $-3.53 |
| 2015 | $185.28M | $-178.68M | $-21.53 |
| 2014 | $206.98M | $-12.88M | $-1.59 |
| 2013 | $204.72M | $-82.23M | $-10.25 |
| 2012 | $196.28M | $-15.46M | $-2.06 |
Valuation
ATEChas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
15-50.00%Social Signal Score
Mentions (12)
- Newsglobenewswire.com·11d ago·Negative
Alphatec Holdings, Inc. (NASDAQ: ATEC) INVESTIGATION ALERT: Portnoy Law Firm Announces Investigation into Alphatec Holdings, Inc. Concerning Potential Securities Fraud LOS ANGELES, Nov. 11, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm announces that it is investigating potential securities fraud claims on behalf of investors of Alphatec Holdings, Inc. (NASDAQ: ATEC). The investigation concerns whether Alphatec and certain of its officers and directors allegedly engaged in unlawful business prac…
View source ↗ - Newsseekingalpha.com·16d ago·Neutral
Alphatec: More Surgeries, Less Revenue Per Procedure Alphatec Holdings is rated Hold with a $7.80 target, reflecting strong surgical volume growth but declining revenue per procedure and persistent cash flow challenges. Q3 saw 20% more surgeries and 25% more new surgeons, but a 5% drop in revenue per surgery due to weaker biologics sales, impacting overall revenue quality. Gross margin improved to 71.5%, yet margin gains were partly driven by a lower biologics mix, while negative free cash flow
View source ↗ - Newsseekingalpha.com·16d ago·Neutral
Alphatec: Earnings-Related Selloff Could Provide Another Buying Opportunity In recent years, Alphatec Holdings has consistently outperformed sales expectations and gained share in the $8 billion U.S. spinal disorder treatment market. However, FY2026 is not playing out as initially expected by management. Last week, Alphatec reported disappointing Q3 results and reduced full-year expectations for revenue, Adjusted EBITDA and free cash flow. Management attributed the shortfall to a combination of
View source ↗ - Newsbusinesswire.com·18d ago·Negative
ATEC Investors Have Opportunity to Join Alphatec Holdings, Inc. Fraud Investigation with SBS Law LOS ANGELES--(BUSINESS WIRE)---- $ATEC--ATEC Investors Have Opportunity to Join Alphatec Holdings, Inc. Fraud Investigation with SBS Law.
View source ↗ - Newsbarrons.com·23d ago·Negative
Alphatec Plunges 32%. A Bone-Graft Slump Hits the Spine Specialist's Stock. Alphatec slashes its full-year outlook as fewer surgeons have purchased its add-on bone-graft products used for spinal fusion.
View source ↗ - Newsseekingalpha.com·24d ago·Neutral
Alphatec Holdings, Inc. (ATEC) Q3 2026 Earnings Call Transcript Alphatec Holdings, Inc. (ATEC) Q3 2026 Earnings Call Transcript
View source ↗ - Newsmarketbeat.com·24d ago·Negative
Alphatec Q3 Earnings Call Highlights Alphatec NASDAQ: ATEC reported third-quarter revenue growth and expanded profitability, while lowering its full-year outlook to reflect weaker biologics performance, softer thoracolumbar procedure volumes and a temporary international supply constraint.
View source ↗ - Newszacks.com·24d ago·Negative
Alphatec (ATEC) Q3 Earnings and Revenues Lag Estimates Alphatec (ATEC) came out with quarterly earnings of $0.09 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.03 per share a year ago.
View source ↗ - Newsbusinesswire.com·34d ago·Negative
ATEC to Report Third Quarter 2026 Financial Results on October 29, 2026 CARLSBAD, Calif--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report third quarter 2026 financial results on October 29, 2026, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET.WebcastTo access the live webcast, please use this link or visit…
View source ↗ - Newsdefenseworld.net·52d ago·Negative
Reviewing LogicMark (OTCMKTS:LGMKD) & Alphatec (NASDAQ:ATEC) Alphatec (NASDAQ: ATEC - Get Free Report) and LogicMark (OTCMKTS:LGMKD - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, analyst recommendations, institutional ownership, earnings and dividends. Analyst Recommendations This is a summary of current ratings
View source ↗ - Newsbusinesswire.com·60d ago·Negative
ATEC Appoints Tommy Carls Executive Vice President, Data Intelligence and Strategy CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced that Thomas "Tommy" Carls has joined the company as Executive Vice President, Data Intelligence and Strategy. Carls will report directly to Chairman and Chief Executive Officer, Pat Miles, and will serve as a member o…
View source ↗ - Newszacks.com·69d ago·Negative
Alphatec (ATEC) Moves 19.7% Higher: Will This Strength Last? Alphatec (ATEC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
View source ↗
Earnings
Tue, Feb 23(in 3 months)
Consensus estimate $0.12 per share
Typical surprise +0.8% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Oct 29$0.09 vs $0.10miss
- Tue, Aug 4$0.07 vs $0.07beat
- Tue, May 5$-0.22 vs $-0.01miss
- Tue, Feb 24$0.06 vs $0.04beat
- Thu, Oct 30$0.03 vs $-0.03beat
- Thu, Jul 31$0.02 vs $-0.06beat
Estimates and results for ATEC via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by ATEC officers and directors.
- Bought
- $2.7m
- Sold
- $76.5m
6 trades
37 trades
- Valentine Keithbought
- Demski David Mbought
- Miles Patrickbought
- Marshall Tyson Eliotsold
- Mcginnis Karen Ksold
- Valentine Keithbought
- Valentine Keithbought
- Valentine Keithbought
57 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in ATEC.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
